Last kr887.50 DKK
Change Today -18.00 / -1.99%
Volume 1.3M
NOVOB On Other Exchanges
Symbol
Exchange
Copenhagen
New York
OTC US
Xetra
Frankfurt
As of 11:05 AM 06/19/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Stig Strøbæk

Director and Member of Audit Committee, Novo Nordisk A/S
AgeTotal Calculated CompensationThis person is connected to 11 board members in 1 different organizations across 1 different industries.

See Board Relationships
48$500,000

Background*

Mr. Stig Strøbæk has been a Director of Novo Nordisk A/S and of the Board of Governors of the Novo Nordisk Foundation, holding Company of Novo Nordisk A/S since 1998. Mr. Strøbæk is presently working in Product Supply as an electrician. Mr. Strøbæk has been re-elected by the employees in March 2002.

Corporate Headquarters*

Novo Allé
Bagsvaerd, Capital Region of Denmark 2880

Denmark

Phone: 45 44 44 88 88
Fax: 45 44 49 05 55

Board Members Memberships*

1998-Present
Director and Member of Audit Committee

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensationkr500,000
Total Calculated Compensationkr500,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVOB:DC kr887.50 DKK -18.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.6M
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
610.0K GBP
Rakesh Kapoor Chief Executive Officer, Executive Director and Member of Nomination Committee
Reckitt Benckiser Group plc
2.6M GBP
Yasuchika Hasegawa Chief Executive Officer, President and Representative Director
Takeda Pharmaceutical Company Limited
--
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVO NORDISK A/S-B, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.